SEC Form 3 · accession 0001209191-16-147037
Myovant Sciences Ltd. · MYOV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marianne L. Romeo
Officer — Head,Global Trans. & Risk Mgmt
Period of report
Oct 26, 2016
Accepted (ET)
Oct 26, 2016 · 8:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001679082
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $2.42 | holding | — | — | — | — | Sep 11, 2026 | Common Shares | 14,102 | — | D |
Explanation of responses
- F11/4th of the shares shall vest and become exercisable on September 12, 2017; the balance of the shares shall vest and become exercisable in a series of twelve (12) successive equal quarterly installments measured from September 12, 2017, subject to the Reporting Person providing continuous service to the Issuer on each such date.
Remarks
Exhibit List - Exhibit 24 - Power of Attorney